This bill establishes regulations regarding the use of di(2-ethylhexyl) phthalate (DEHP) and other ortho-phthalates in intravenous solution containers and tubing in Washington State. It recognizes the toxic nature of DEHP, which is commonly used as a plasticizer in medical devices, and its potential health risks, including endocrine disruption and links to certain cancers. The bill prohibits the manufacture, sale, or distribution of intravenous solution containers containing intentionally or unintentionally added DEHP in quantities of 0.1 percent or more, starting January 1, 2030, and extends this prohibition to intravenous tubing by January 1, 2035. Exemptions are provided for specific blood collection and storage bags, and provisions are included for manufacturers facing FDA approval delays.

Additionally, the bill outlines definitions for terms related to DEHP and establishes a framework for compliance, including notification requirements for manufacturers. It allows for temporary exceptions in the event of a supply chain interruption as determined by health authorities. The legislation aims to protect public health by reducing exposure to harmful chemicals in medical equipment while ensuring that the Department of Ecology retains its regulatory authority over these substances.